Sign in or Register

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

By Application


Creative Biolabs provides a range kind of recombinant antibodies to meet our clients’ needs, such as immunoglobulin detection.

A test for quantitative immunoglobulins is used to detect an excess or deficiency in the three major classes of immunoglobulins. It gives important information about the health of an individual’s immune system and is used to help diagnose various conditions and diseases that affect the levels of one or more of these Ig classes. Immunoglobulins, also called antibodies, are proteins produced by plasma cells. They target specific “threats” and play a key role in the body’s immune system. Immunoglobulins are produced in response to exposure to bacteria, viruses, and other microorganisms as well as other substances that are recognized by the body as “non-self” harmful antigens.